What does Eli Lilly and Company do?

Eli Lilly and Company (LLY.TO) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is LLY.TO's market cap?

Eli Lilly and Company (LLY.TO) has a market capitalization of approximately $1.55 trillion, as of August 21, 2026, based on the most recent share price and shares outstanding.

Does LLY.TO pay a dividend?

Yes — Eli Lilly and Company (LLY.TO) pays a dividend quarterly, with a trailing-twelve-month yield of 0.53%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

LLY.TO (Eli Lilly and Company) is a recent IPO.

It began trading on December 22, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.

LLY.TO

Eli Lilly and Company

TSX·Drug Manufacturers, General · Healthcare

C$45.02C$0.36+0.81%

Market capC$1.55T·Market closed·Aug 21 7:59 PM UTC

Price Chart

C$45.02+C$0.36 (+0.81%)today

+15.20%

Select date range

FromTo

Dec 22, 2025Dec 22, 2025 → Aug 23, 2026· 8 moAug 23, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.55%

Annual Dividend (FWD)C$0.25

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio22.1%

FCF Payout Ratio—

Most Recent DividendC$0.062

Ex-Dividend DateAug 14

Payment DateSep 17

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how LLY.TO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for LLY.TO and 80,000+ other tickers.

About Eli Lilly and Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

CEO: David A. Ricks
Sector: Healthcare
Industry: Drug Manufacturers - General
Exchange: TSX
Employees: 50,000
Website: www.lilly.com

Latest News

News Tab

No recent news available.

Frequently Asked Questions About LLY.TO

What does Eli Lilly and Company do?: Eli Lilly and Company (LLY.TO) operates in the Drug Manufacturers - General industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is LLY.TO's market cap?: Eli Lilly and Company (LLY.TO) has a market capitalization of approximately $1.55 trillion, as of August 21, 2026, based on the most recent share price and shares outstanding.
Does LLY.TO pay a dividend?: Yes — Eli Lilly and Company (LLY.TO) pays a dividend quarterly, with a trailing-twelve-month yield of 0.53%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.